An observational study in Idiopathic Granulomatous Mastitis, sponsored by Medipol University. Status unknown at 1 site in Turkey. Open to female participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-09-19.
Sponsored by Medipol University · Observational
Collaboration is established between Turkish Holistic \& Integrative Medicine Association and Traditional \& Complementary Medicine Society of Istanbul Medipol University.
Study is carried out on idiopathic granulomatous mastitis patients who are followed in the Breast Clinic at Istanbul Medipol University Hospital for between September 2015 and September 2019. Hirudotherapy and medical cupping therapy were applied as traditional and complementary medicine integratively.
Following initial radiological imaging, microbiological- and histological testing, side effects and relapses are analyzed. Follow-up examination is also carried out at the end of the treatment, which consisted of clinical breast exam and radiological imaging.
22 studies on the registry are indexed under Granulomatous Mastitis; 7 are open to participants now.
This study's enrollment of 30 is below the median of 79 across 10 observational studies indexed under Granulomatous Mastitis.
Browse Granulomatous Mastitis studies →Medipol University is the lead sponsor of 326 studies on the registry; 88 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients receiving Traditional and Complementary Medicine (T\&CM) for IGM will be retrospectively analyzed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Change of Breast Mass Size
Ultrasonic scan at 6 months
Time frame: Up to 12 months
Change of Breast Mass Size
Ultrasonic scan at 12 months
Time frame: Up to 48 months
Change of Breast Mass Size
MRI scan at 12 months, if prompted by ultrasonic scan
Time frame: Up to 48 months
Started Jun 2019 (actual). Primary completion is estimated for Sep 2019, 3 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.